SDI Group plc
("SDI", the "Company", or the "Group")
Director/PDMR Shareholding, Exercise of Share Options and Total Voting Rights
SDI Group plc, the AIM quoted group focused on the design and manufacture of scientific and technology products for use in digital imaging and sensing and control applications, announces that it has been notified that Mike Creedon, Chief Executive Officer, has purchased 42,606 shares at an weighted average price of 116 pence.
Further to the above, the Company also announces that it has issued and allotted a total of 30,000 new ordinary shares of 1 penny each in the capital of the Company ("Ordinary Shares") following an exercise of options by a non PDMR employee.
Application has been made to the London Stock Exchange for the 30,000 new Ordinary Shares to be admitted to trading on AIM ("Admission") and it is expected that Admission will become effective and trading will commence at 8:00 a.m. on or around 10 November 2023.
Following Admission, the total number of Ordinary Shares in issue will be 104,080,044 and the total number of voting rights will therefore be 104,080,044. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA's Disclosure Guidance and Transparency Rules.
Following the purchase and Admission, Mike Creedon will hold 393,978 Ordinary Shares, representing 0.38% of the total issued share capital.
Enquiries
SDI Group plc
Mike Creedon, CEO 01223 727144
Ami Sharma, CFO
Cavendish Capital Markets Limited 020 7220 0500
Ed Frisby/Seamus Fricker - Corporate Finance
Andrew Burdis/Sunila de Silva - ECM
About SDI Group plc:
SDI designs and manufactures scientific and technology products for use in digital imaging and sensing and control applications including life sciences, healthcare, astronomy, plastics and packaging, manufacturing, precision optics, measurement instrumentation and art conservation. SDI operates through its subsidiaries: Atik Cameras, Synoptics, Graticules Optics, Sentek, Astles Control Systems, Applied Thermal Control, MPB Industries, Chell Instruments, Monmouth Scientific, Uniform Engineering, Scientific Vacuum Systems, Safelab Systems, LTE Scientific, Fraser Anti-Static Techniques and Peak Sensors.
SDI continues to grow by developing its own technology advancements and by improving its global sales channels, as well as through pursuing strategic, complementary acquisitions.
| 1. | Details of the person discharging managerial responsibilities / person closely associated | ||||||||||
| a) | Name | Mike Creedon | |||||||||
| 2. | Reason for the Notification | ||||||||||
| a) | Position/status | Chief Executive Officer | |||||||||
| b) | Initial notification/Amendment | Initial Notification | |||||||||
| 3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||||||||||
| a) | Name | SDI Group plc | |||||||||
| b) | LEI | 213800YA3XW7JRE46Z70 | |||||||||
| 4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||||||||
| a) | Description of the Financial instrument, type of instrument | Ordinary Shares of 1p each | |||||||||
| Identification code | GB00B3FBWW43 | ||||||||||
| b) | Nature of the transaction | Purchase of Ordinary Shares | |||||||||
| c) | Price(s) and volume(s) |
| |||||||||
| d) | Aggregated information: ·Aggregated volume ·Price |
42,606 Weighted average price of 116 pence | |||||||||
| e) | Date of the transaction | 6 November 2023 | |||||||||
| f) | Place of the transaction | Purchase at 117 pence - London Stock Exchange (AIM - XLON) Purchase at 115 pence - Outside a trading venue | |||||||||
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
